企業プロフィール · Healthcare

IDEXX Laboratories Inc

IDXX · 米国株
取引所
米国株
国 / 地域
USA
上場日
1991年6月21日
従業員数
11,000
公式サイト
www.idexx.com
現在値
$562.09
リアルタイム · 2026年6月18日
ベイリー成長スコア
47/100
やや弱い
本源的価値 · 3 段階レンジ 現在値 $562.09 リアルタイム · 楽観的シナリオの上限を超過 · 将来の成長を先取り

総合バリュエーションレンジ · 保守的 $240–$290 / 妥当 $300–$380 / 楽観的 $400–$480。$562.09 時点で 楽観的シナリオの上限を超過 · 将来の成長を先取り。

レポート公開時 $563(2026年5月22日)

この銘柄のレポートはお使いの言語でまだありません。

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and SNAP rapid assays test kits. It also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; UV Viewer Plus, a UV light cabinet which aids in the visual interpretation of fluorescent-based water tests; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, the company offers diagnostic tests, services, and related instrumentation to manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. It markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

時価総額$430.77億
売上高(TTM)$44.46億
EBITDA$15.46億
純利益率24.63%
ROE72.92%
PER (TTM)40.21
予想PER37.04
PEG3.5
EPS$13.58
52週レンジ$506.91 – $769.98
アナリスト目標株価$709.14
アナリスト評価3.6 / 5

データ提供:EODHD、報告通貨で表示。参考情報であり、投資助言ではありません。

沿革

近日公開このセクションは現在準備中です。近日公開予定です。

業界での地位

近日公開このセクションは現在準備中です。近日公開予定です。